The forecast is based on already signed contracts for 1.6bn vaccine doses to be delivered this year. Pfizer and BioNTech aim to produce up to 2.5bn Covid vaccine doses this year, 900m of which are not yet included in the New York-based drugmaker's sales forecast. If Pfizer sells that number of doses at similar prices, the vaccine's sales in 2021 could be more than 50% above the projected $26bn. ModernaUS rival Moderna has forecast $18.4bn in 2021 sales of its similar Covid vaccine. Its drug is at the heart of the Pfizer vaccine, which has suffered less from turbulence than other rival vaccine makers.
Source: Irish Examiner May 04, 2021 16:20 UTC